These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 36389124)

  • 1. The Importance of Correlation between Aldosterone and Parathyroid Hormone in Patients with Primary Hyperparathyroidism.
    Milicic Stanic B; Ilincic B; Zeravica R; Milicic Ivanovski D; Cabarkapa V; Mijovic R
    Int J Endocrinol; 2022; 2022():3804899. PubMed ID: 36389124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aldosterone and parathyroid hormone interactions as mediators of metabolic and cardiovascular disease.
    Tomaschitz A; Ritz E; Pieske B; Rus-Machan J; Kienreich K; Verheyen N; Gaksch M; Grübler M; Fahrleitner-Pammer A; Mrak P; Toplak H; Kraigher-Krainer E; März W; Pilz S
    Metabolism; 2014 Jan; 63(1):20-31. PubMed ID: 24095631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dynamic changes of renin-angiotensin-aldosterone system parameters after surgery of primary hyperparathyroidism].
    Dobreva EA; Bibik EE; Eremkina AK; Ajnetdinova AR; Nikankina LV; Malysheva NM; Mokrysheva NG
    Ter Arkh; 2020 Nov; 92(10):63-69. PubMed ID: 33346481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Interplay Between the Renin-Angiotensin-Aldosterone System and Parathyroid Hormone.
    Zheng MH; Li FX; Xu F; Lin X; Wang Y; Xu QS; Guo B; Yuan LQ
    Front Endocrinol (Lausanne); 2020; 11():539. PubMed ID: 32973674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parathyroid hormone, aldosterone-to-renin ratio and fibroblast growth factor-23 as determinants of nocturnal blood pressure in primary hyperparathyroidism: the eplerenone in primary hyperparathyroidism trial.
    Verheyen N; Fahrleitner-Pammer A; Pieske B; Meinitzer A; Belyavskiy E; Wetzel J; Gaksch M; Grübler MR; Catena C; Sechi LA; Van Ballegooijen AJ; Brandenburg VM; Scharnagl H; Perl S; Brussee H; März W; Pilz S; Tomaschitz A
    J Hypertens; 2016 Sep; 34(9):1778-86. PubMed ID: 27379537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aldosterone and pressor responses to angiotensin II in primary hyperparathyroidism.
    Fallo F; Rocco S; Pagotto U; Zangari M; Luisetto G; Mantero F
    J Hypertens Suppl; 1989 Dec; 7(6):S192-3. PubMed ID: 2632714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating the clinical and mechanistic effects of eplerenone and amiloride monotherapy, and combination therapy with cinacalcet, in primary hyperparathyroidism: A placebo-controlled randomized trial.
    Parksook WW; Heydarpour M; Brown JM; Turchin A; Mannstadt M; Vaidya A
    Clin Endocrinol (Oxf); 2023 Apr; 98(4):516-526. PubMed ID: 36316798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum aldosterone is correlated positively to parathyroid hormone (PTH) levels in patients with primary hyperparathyroidism.
    Brunaud L; Germain A; Zarnegar R; Rancier M; Alrasheedi S; Caillard C; Ayav A; Weryha G; Mirallie E; Bresler L
    Surgery; 2009 Dec; 146(6):1035-41. PubMed ID: 19958930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperparathyroidism can be useful in the identification of primary aldosteronism due to aldosterone-producing adenoma.
    Rossi GP; Ragazzo F; Seccia TM; Maniero C; Barisa M; Calò LA; Frigo AC; Fassina A; Pessina AC
    Hypertension; 2012 Aug; 60(2):431-6. PubMed ID: 22733469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between parathyroid hormone and renin-angiotensin-aldosterone system in hemodialysis patients with secondary hyperparathyroidism.
    Kono K; Fujii H; Watanabe K; Goto S; Nishi S
    J Bone Miner Metab; 2021 Mar; 39(2):230-236. PubMed ID: 32920706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The renin-angiotensin-aldosterone system (RAAS) and its relation with calcium homeostasis in male obesity.
    Ozata M; Durmus O; Yilmaz MI; Bolu E; Erdogan M; Ozdemir IC
    Med Sci Monit; 2002 Jun; 8(6):CR430-4. PubMed ID: 12070434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aldosterone Secretion in Patients With Primary Hyperparathyroidism Without Arterial Hypertension.
    Castellano E; Pellegrino M; Tardivo V; Attanasio R; Boriano A; Borretta G
    Endocr Pract; 2021 Nov; 27(11):1072-1076. PubMed ID: 33965584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of surgical treatment on secondary hyperaldosteronism and relative hyperinsulinemia in primary hyperparathyroidism.
    Kovács L; Góth MI; Szabolcs I; Dohán O; Ferencz A; Szilágyi G
    Eur J Endocrinol; 1998 May; 138(5):543-7. PubMed ID: 9625366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations of calcium metabolism and of parathyroid function in primary aldosteronism, and their reversal by spironolactone or by surgical removal of aldosterone-producing adenomas.
    Rossi E; Sani C; Perazzoli F; Casoli MC; Negro A; Dotti C
    Am J Hypertens; 1995 Sep; 8(9):884-93. PubMed ID: 8541003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renin-angiotensin-aldosterone system in primary hyperparathyroidism before and after surgery.
    Bernini G; Moretti A; Lonzi S; Bendinelli C; Miccoli P; Salvetti A
    Metabolism; 1999 Mar; 48(3):298-300. PubMed ID: 10094103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ECHOCARDIOGRAPHIC FINDINGS IN PATIENTS WITH NORMOCALCEMIC PRIMARY HYPERPARATHYROIDISM COMPARED WITH FINDINGS IN HYPERCALCEMIC PRIMARY HYPERPARATHYROID PATIENTS AND CONTROL SUBJECTS.
    Pepe J; Colangelo L; Sonato C; Occhiuto M; Ferrara C; Del Fattore A; Santori R; Mastrantonio M; Sgreccia A; Minisola S; Cipriani C
    Endocr Pract; 2021 Jan; 27(1):21-26. PubMed ID: 33475498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Posterior urethral valves: Metabolic consequences in a cohort of patients.
    Sarhan O; Nakshabandi Z; Alghanbar M; Alotay A; Sherif I; Whitehead C; El-Husseini A
    J Pediatr Urol; 2015 Aug; 11(4):216.e1-6. PubMed ID: 26096436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aldosterone and parathyroid hormone: a precarious couple for cardiovascular disease.
    Tomaschitz A; Ritz E; Pieske B; Fahrleitner-Pammer A; Kienreich K; Horina JH; Drechsler C; März W; Ofner M; Pieber TR; Pilz S
    Cardiovasc Res; 2012 Apr; 94(1):10-9. PubMed ID: 22334595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term inhibition of parathyroid hormone secretion by a calcium-receptor agonist in patients with primary hyperparathyroidism.
    Silverberg SJ; Bone HG; Marriott TB; Locker FG; Thys-Jacobs S; Dziem G; Kaatz S; Sanguinetti EL; Bilezikian JP
    N Engl J Med; 1997 Nov; 337(21):1506-10. PubMed ID: 9366582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium metabolism and parathyroid function in primary aldosteronism.
    Resnick LM; Laragh JH
    Am J Med; 1985 Mar; 78(3):385-90. PubMed ID: 3883768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.